November 21, 2023
Managing Intellectual Property
Patent attorneys are noting an uptick in inventorship issues within their practices. At present, the law states that only those who have made independent, conceptual contributions to an invention can be named as an inventor. If improper information is listed on a patent, it can be invalidated if the inventorship isn’t correct.
Managing Intellectual Property spoke with Finnegan partner Mark Feldstein and he said generics companies frequently claim that there are inventorship issues with innovator businesses’ patents.
“It seems to be a standard attack to try to invalidate innovator patents in the pharma area,” he said.
Mark hasn’t advised patent owners in cases where the other side was able to invalidate the patents based on improper inventorship. But it can still be an important issue, he said.
As a result, he focuses on inventorship in the pre-litigation preparation and makes sure to correct it if there’s a problem.
“It has really affected how much time and effort we spend looking at inventorship pre-litigation,” he said.
Read “Too Many Cooks: Inventorship an Increasing Problem for Patent Counsel”
Award/Ranking
Best Lawyers in Germany Recognizes Dr. Dr. Jochen Herr in Recent Rankings
July 16, 2026
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Commentary
U.S. Judge Rules Forum-Selection Clause Bars Zync from Pursuing ITC Trade Secret Case
June 15, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.